Literature DB >> 3027330

Structure-activity relationships of kadsurenone analogues.

M M Ponpipom, R L Bugianesi, D R Brooker, B Z Yue, S B Hwang, T Y Shen.   

Abstract

Kadsurenone, a specific receptor antagonist of platelet-activating factor (PAF), and its analogues were prepared from derivatives of cinnamyl alcohol and (allyloxy)phenol. Racemic kadsurenone, resolvable by a Chiralpak column at low temperatures, has an IC50 value of 2 X 10(-7) M, which is about 50% of the activity of the natural product (IC50 = 1 X 10(-7) M). The structural specificity of kadsurenone was further demonstrated by the low PAF-receptor-blocking activities of denudatin B, mirandin A, desallylkadsurenone, and the 2-epimer of kadsurenone.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3027330     DOI: 10.1021/jm00384a023

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

Review 1.  Chemical and biochemical characterization of lignan analogs as novel PAF receptor antagonists.

Authors:  T Y Shen
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

2.  SILAC-based chemoproteomics reveals a neoligan analogue as an anti-inflammatory agent targeting IRGM to ameliorate cytokine storm.

Authors:  Jichao Zhang; Yang Li; Guibing Meng; Kui Lu; Jiankun Yan; Jiangpeng Wu; Pengyan Li; Lingling Luo; Xi Chen; Xia Zhao; Feng Qiu
Journal:  Eur J Med Chem       Date:  2022-08-08       Impact factor: 7.088

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.